European Markets Stall as Energy Costs and Political Uncertainty Mount

Swiss and German equities bore the brunt of the session’s volatility. Novartis acted as a significant drag on broader indices after a high-profile drug trial failed to meet its primary objectives, casting a shadow over the pharmaceutical sector. Beyond individual corporate setbacks, the broader economic sentiment remains fragile.

Investors are now turning their attention toward incoming economic data, which will serve as a bellwether for the European Central Bank’s policy path. With energy markets reacting sharply to Middle Eastern instability, the prospect of prolonged high interest rates is complicating the outlook for eurozone growth.